ArticleFrontiers in endocrinology2024

Short-term effect of low-dose roxadustat combined with erythropoiesis-stimulating agent treatment for erythropoietin-resistant anemia in patients undergoing maintenance hemodialysis.

Qiaoying Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.